Administration to Arthritis Patients of a Dietary Supplement Containing Immune Egg: An Open-Label Pilot Study

Journal of Medicinal Food

Volumn 1, Issue 3, 1998, Pages 171-179

  Greenblatt, Hellen C ^a   Adalsteinsson, Orn ^a   Kagen, Lawrence ^b  

^a DCV Biologics   (United States)

^b Weill Cornell Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949549100     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.1998.1.171     Document Type: Article

References (57)

1. Albani, S. and Carson, D. A. (1996). Multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis. Immunol Today 17, 10.
2. Breedveld, F. C., Dijkmans, B. A., and Mattie, H. (1990). Minocycline treatment for rheumatoid arthritis: An open dose finding study. J Rheumatol 17, 43–46.
3. Brunser, O., Espinoza, J., Figueroa, G., Araya, M., Spencer, E., Hilpert, H., Link-Amster, H., and Briissow, H. (1992). Field trial of an infant formula containing anti-rotavirus and anti-Escherichia coli milk antibodies from hyperimmunized cows. J Pediatr Gastroenterol Nutr 15, 63–72.
4. Darlington, L. G. (1991). Dietary therapy for arthritis. Rheum Dis Clin North Am 17, 272–285.
5. Detrick, B. and Hooks, J. J. (1997). Cytokines in human immunology. In Handbook of Human Immunology. M. S. Leffell, A. D. Donnenberg, and N. R. Rose, eds. (CRC Press, New York) pp. 233–266.
6. Firestein, G. S. and Zvaifler, N. J. (1997). Anticytokine therapy in rheumatoid arthritis. N Engl J Med 337, 195–197.
7. Flynn, M. A., Irvin, W., and Krause, G. (1994). The effect of folate and cobalamin on osteoarthritic hands. J Am Nutr 13, 351–356.
8. Fujinami, R. S. (1992). Molecular Mimicry. In The Autoimmune Diseases II. N. R. Rose and I. R. Mackay, eds. (Academic Press, New York) pp. 153–169.
9. Golay, A., Ferrara, J. M., Felber J. P., and Schneider, H. (1990). Cholesterol-lowering effect of skim milk from immunized cows in hypercholesterolemic patients. Am J Clin Nutr 52,1014–1019.
10. Greenblatt, H. C., Adalsteinsson, O., Brodie, D. A., and Fitzpatrick-McElligott, S. G. (1998). Method of preventing, countering or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals. U. S. patent 5,772,999, June 30, 1998.
11. Hajjar, D. P. and Pomerantz, K. B. (1992). Signal transduction in atherosclerosis: Integration of cytokines and the eicosanoid network. FASES J 6, 2933–2941.
12. Hammarström, L., Gardulf, A., Hammarström, V., Janson, A., Lindberg, K., and Smith, CLE. (1994). Systemic and topical immunoglobulin treatment in immunocompromised patients. Immunol Rev 139, 43–70.
13. Hilpert, H., Brussow, H., Mietens, C., Sidoti, J., Lerner, L., and Werchau, H. (1987). Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis 156,158–166.
14. Hunchar, J. G. (in preparation). The effect of egg powder on acute carrageenin-induced inflammation in female beagle dogs.
15. Jacoby, H., Brodie, D., Wnorowski, G., and Moore, G. (in preparation). Inhibition of castor oil-induced diarrhea in mice by eggs from hyperimmunized chickens.
16. Kamradt, T. and Burmester, G. R. (1998). Cytokines and arthritis: Is the Th1/Th2 paradigm useful for understanding pathogenesis? J Rheum 25, 6–7.
17. Karge, W. H., Tharion, W., Tulley, R., Greenblatt, H. C., Adalsteinssön, O., and Lieberman, H. R. (1998). Effect of an egg protein nutrient drink on serum lipid and apolipoprotein values [abstract] FASEB J 12,1231.
18. Karge, W. H., Tharion, W., Tulley, R., and Lieberman, H. R. (in preparation). A double-blind placebo controlled study of the effect of hyperimmune egg protein on elevated cholesterol levels and cardiovascular risk.
19. Kavanaugh, A. R. and Lipsky, P. E. (1994). Application of biotechnological advances to treatment of rheumatoid arthritis. In Rheumatoid Arthritis: Pathogenesis, Assessment, Outcome, and Treatment F. Wolfe and T. Pincus, eds. (Marcel Dekker, New York) pp. 373–401.
20. Kingsley, G., Pitzalis, C., and Panayi, G. (1990). Immunogenetic and cellular immune mechanisms in rheumatoid arthritis: Relevance to new therapeutic strategies. Br J Rheumatol 429, 58–64.
21. Kingsley, G., Panayi, G., and Lanchbury, J. (1991). Immunotherapy of rheumatic diseases practice and prospects. Immunol Today 12,177–179.
22. Klinenberg, J. R. (1985). 1984r-2034: The next half-century for American rheumatology [ARA Presidential Address]. Arthritis Rheum 28,1–7.
23. Kloppenburg, M., Breedveld, F. C., Miltenburg, A. M., and Dijkmans, B. A. (1993). Antibiotics as disease modifiers in arthritis. Clin Exp Rheum 8, S113-S115.
24. Kloppenburg, M., Breedveld, F. C., Terwiel, J., Mallee, C., and Dukmans, B. A. (1994). Minocycline in active rheumatoid arthritis: A double-blind, placebo controlled trial. Arthritis Rheum 37, 629–636.
25. Kühlmann, R., Wiedemann, W., Schmidt, P., Wanke, R., Linckh, E., and Losch, U. (1988). Chicken egg antibodies for prophylaxis and therapy of infectious intestinal diseases. I. Immunization and antibody determination. J Vet Med B 35, 610–616.
26. Kuroki, M., Ohta, Y., Ikemoris, R. C., Peralta, R. C., Yokoyama, H., and Kodma, Y. (1994). Passive protection against bovine rotavirus in calves by specific immunoglobulins from chicken egg yolk. Arch Virol 138, 141–148.
27. Langevitz, P., Bank, L., Zemer, D., Book, M., and Pras, M. (1992). Treatment of resistant rheumatoid arthritis with minocycline: An open study. J Rheumatol 19,1502–1504.
28. Luster, A. D. (1998). Chemokines: Chemotactic cytokines that mediate inflammation. N Engl J Med 338, 436–445.
29. McPherson-Brown, T., Hochberg, M. D., and Hicks, J. T. (1985). Antibiotic therapy of rheumatoid arthritis: A retrospective cohort study of 98 patients with 451 patient-years of follow-up [abstract]. Congress of Rheumatology, S85.
30. Ormrod, D. J. and Miller, T. E. (1991). The anti-inflammatory activity of a low molecular weight component derived from the milk of hyperimmunized cows. Agents Actions 32,160–166.
31. Ormrod, D. J. and Miller, T. E. (1992). A low molecular weight component derived from the milk of hyperimmunized cows suppresses inflammation by inhibition neutrophil emigration. Agents Actions 37, 70–78.
32. Ormrod, D. J. and Miller, T. E. (1993). Milk from hyperimmunized dairy cows as a source of a novel biological response modifier. Agents Actions 38 (Special Conference Issue), C146-C149.
33. Owens, W. E. and Nickerson, S. C. (1988). Evaluation of an anti-inflammatory factor derived from hyperimmunized cows. Proc Soc Exp Biol Med 190, 79–86.
34. Panush, R. S. (1993). Arthritis, food allergy, diets, and nutrition. In Arthritis and Allied Conditions. D. J. McCarty and W. J. Koopman, eds. (Lea & Febiger, Philadelphia) pp. 1139–1146.
35. Paulus, H. E., Machleder, H. I., Levine, S., Yu, D. T. Y., and MacDonald, N. S. (1977). Lymphocyte involvement in rheumatoid arthritis: Studies during thoracic duct drainage. Arthritis Rheum 20,1249–1262.
36. Plewig, G. and Schopf, E. (1975). Anti-inflammatory effects of antimicrobial agents: An in vivo study. J Invest Dermatol 65, 532–536.
37. Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., and Hennekens, C. H. (1997). Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336, 973–979.
38. Ritchie, D. J. and Becker, E. S. (1994). Update on the management of intestinal cryptosporidiosis in AIDS. Ann Pharmacother 28, 767–778.
39. Rogler, G. and Nadus, T. (1998). Cytokines in inflammatory bowel disease. World J Surg 22, 382–389.
40. Sanchez, I. (1968). Tetracycline treatment in rheumatoid arthritis and other rheumatic diseases. Braz J Med 82, 21–31.
41. See, D. M. (1998). Complementary therapies in arthritis. J Am Nutraceutical Assoc 1, 7–14.
42. Sewell, K. L. and Trentham, D. E. (1993). Pathogenesis of rheumatoid arthritis. Lancet 341, 283–286.
43. Sewell, K. L., Breedveld, F., Furrie, E., O'Brien, J., Brinckerhoff, C., Dynesius-Trentham, R., Nosaka, Y., and Trentham, D. E. (1996). The effect of minocycline in rat models of inflammatory arthritis: Correlation of arthritis suppression with enhanced T cell calcium flux. Cell Immunol 167, 195–204.
44. Sharpe, S. J., Gamble, G. D., and Sharpe, D. N. (1994). Cholesterol-lowering and blood pressure effects of immune milk. Am J Clin Nutr 59, 929–934.
45. Skinner, M., Cathcart, E. S., Mills, J. A., and Pinals, R. S. (1971). Tetracycline in the treatment of rheumatoid arthritis: A double blind controlled study. Arthritis Rheum 14, 727–732.
46. Smith, C. M. (1964). Immune milk in the treatment of the rheumatoid arthritis syndrome. J Immune Milk 1,37–42.
47. Stephan, W., Dichtelnuiller, H., and Lissner, R. (1990). Antibodies from colostrum in oral immunotherapy. J Clin Chem Clin Biochem 28, 19–23.
48. Strober, S., and Holoshitz, J. (1990). Mechanisms of immune injury in rheumatoid arthritis: Evidence for the involvement of T cells and heat-shock protein. Immunol Rev 118, 233–255.
49. Struss, H. E. (1964). Immune milk treatment of rheumatoid arthritis: A review. J Immune Milk 1, 23–24.
50. Tacket, C. O., Losonsky, G., Link, H., Hoang, Y., Guesry, P., Hilpert, H. and Levine, M. M. (1988). Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coll N Engl J Med 318,1240–1243.
51. Tilley, B. C., Alarcón, G. S., Heyse, S. P., Trentham, D. E., Neuner, R., Kaplan, D. A., Clegg, D. O., Leisen, J. C. C., Buckley, L., Cooper, S. M., Duncan, H., Pillemer, S. R., Tuttleman, M., and Fowler, S. E. (1995). Minocyline in rheumatoid arthritis: A 48-week double-blind, placebo controlled trial. Ann Intern Med 122, 81–89.
52. Trentham, D. E., Dynesius-Trentham, R. A., Orav, E. J., Combitchi, D., Lorenzo, C., Sewell, K. L., Hafler, D. A., and Wiener, H. L. (1993). Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261, 1727–1730.
53. Trentham, D., Morales, A., Guerau-de-Arellano, M., Ahmad, T., Dynesius-Trentham, R., Fitzpatrick-McElligott, S., Marvil, P., Xing, R. Greenblatt, H., Adalsteinsson, O., and Kagen, L. (1998). Hyperimmune egg in the collagen-induced arthritis model and anti-inflammatory assays [abstract]. Int Soc Rheum Therap.
54. Tsubokura, K. Berndtson, E., Bogstedt, A., Kaijser, B., Kim, M., Ozeki, M., and Hammarström, L. (1997). Oral administration of antibodies as prophylaxis and therapy in Campylobacter jejuni-iniected chickens. Clin Exp Immunol 108, 451–455.
55. Wolfe, F. and Pincus, T. (1994). Preface In Rheumatoid Arthritis: Pathogenesis, Assessment, Outcome, and Treatment. (Marcel Dekker, New York) pp. iii.
56. Wolfe, F., Kleinheksel, S. M., Spitz, P. W., Lubeck, D. P., Fries, J. F., Young, D. Y., Mitchell, D. M., and Roth, S. H. (1986). A multicenter study of hospitalization in rheumatoid arthritis: Effect of health care system, severity, and regional difference. J Rheumatol 13, 277–284.
57. Yokoyama, H., Peralta, R.C., Umeda, K., Hashi, T., Icatlo, F. C., Kuroki, M., Ikemori, Y., and Kodama, Y. (1998). Prevention of fatal salmonellosis in neonatal calves, using orally administered chicken egg yolk Salmonella-specific antibodies. Am J Vet Res 59, 416–420.